| | ||||||
| "anti diabetes" | ||||||
| NEWS | ||||||
| FDA approves lixisenatide as AdlyxinTM for the treatment of adults with type 2 diabetes in the U.S. ... to diet and exercise for the treatment of adults with type 2 diabetes, including in combination with oral anti-diabetes medication and/or basal insulin.
| ||||||
| You have received this email because you have subscribed to Google Alerts. |
Receive this alert as RSS feed |
| Send Feedback |
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.